Prestige Brand Holdings has initiated a voluntary recall of nearly 40,000 bottles of its Clear Eyes Maximum Itchy Eye Relief eye drops due to concerns regarding the sterility of the product. The U.S. Food and Drug Administration (FDA) has flagged this issue, leading to the removal of these eye drops from store shelves nationwide.
The FDA has classified this recall as Class II, indicating a moderate risk. This means that while exposure to the product might cause temporary or medically reversible adverse health effects, the likelihood of serious health consequences is considered remote. The company is taking this action to ensure product safety and address the potential for contamination.
Prestige Brands Recalls 40,000 Bottles of Clear Eyes Eye Drops for Sterility Concerns
16 stories · 9 sources
#melatonin #cognition #researchOther digests
- 2026-10-03 — New Research Explores Melatonin's Impact on Cognitive Function
- 2026-10-02 — New Drug Tirzepatide Significantly Reduces Fat Mass While Preserving Muscle
- 2026-10-01 — Australian Scientists Uncover Causes of Recurrent Bacterial Vaginosis
- 2026-09-30 — New Brain Wave Patterns Offer Deeper Insight into Neural Activity
- 2026-09-29 — Ukrainian Academy of Sciences, Vital to Nation's Research, Hit by Drone Attack
- 2026-09-28 — Gene-Edited Bananas Developed to Combat Browning, Reduce Food Waste
- 2026-09-27 — UK GPs Overwhelmed, Lacking Time for In-Depth Patient Consultations
- 2026-09-26 — New Pesticide Research Links 485 Chemicals to Breast Cancer
- 2026-09-25 — New Brain Tumour Test Slashes Diagnosis Time from Weeks to Hours
- 2026-09-24 — NHS Faces Two-Year Wait for ADHD, Autism Diagnoses Amid Soaring Demand
- 2026-09-23 — Millions in England Unaware of High Blood Pressure, 'Silent Killer' Risk
- 2026-09-22 — New Non-Invasive Test Offers Hope for Womb Cancer Detection in Postmenopausal Women
- 2026-09-21 — Switzerland Captain Xhaka Faces Ban Over Forged COVID Vaccine Certificate
- 2026-09-20 — Bill Seeks to Bar Private Equity from Owning Medical Practices
- 2026-09-19 — Bilingualism Linked to Enhanced Brain Health and Cognitive Function
- 2026-09-18 — Scientists Identify Brain Cells That May Trigger Sleep
- 2026-09-17 — RFK Jr. Pledges Support to Anti-Vaccine Group Amid Measles Outbreak
- 2026-09-16 — Fiji Declares National Emergency Amidst HIV Epidemic Fueled by Drug Use
- 2026-09-15 — Air Pollution Linked to Increased Suicide Risk, New Research Indicates
- 2026-09-14 — Measles Outbreak Claims Third Life in Pennsylvania; Anti-Vaccine Conference Draws RFK Jr.
- 2026-09-13 — Pennsylvania Reports Third Measles Death; Unvaccinated Woman Succumbs to Complications
- 2026-09-12 — New Research Explores Resistance Training for Muscle Function and Hypertrophy
- 2026-09-11 — Bouncy Castle MRSA Outbreak Infects 48 Children in Ireland
- 2026-09-10 — Esther Rantzen Too Frail for Swiss Assisted Dying
- 2026-09-09 — Apple's Health App to Feature 'Health Age' and Readiness Scores
- 2026-09-08 — Toilet Flushes Disperse Pathogen Plumes, Study Warns
- 2026-09-07 — BBC Anchor Maryam Moshiri Discloses Incurable Blood Cancer Diagnosis
- 2026-09-06 — Alzheimer's Prevention Trial Begins; Pig Kidney Transplant Patient Progresses
- 2026-09-05 — Alzheimer's Prevention Trial Targets Asymptomatic Individuals
- 2026-09-04 — Novartis Heart Drug Pelacarsen Trial Fails, Disappointing Medical Community